Daniel specialises in advising and representing national and international clients in the life sciences sector. His focus is, among others, on all areas of pharmaceutical law, medical device law, pharmaceutical-advertising law, unfair competition law, and trademark law.

 

For more than 10 years, he has been coordinating and supervising disputes concerning competition law and trademark law for his clients and has, besides his specific focus on litigation, also longstanding experience in advising clients on regulatory and compliance matters, particularly, in the aforementioned areas of law. In context with managing litigation and advising his clients, Daniel is characterised by a strong client focus and his ability to find appropriate and efficient solutions to legal problems.

Show full CV Hide full CV

Latest news & insights

Close-Up Of Magnifying Glass
Life sciences & healthcare

Update on cannabis legalisation: working draft of a cannabis law

25 May 2023
Briefing

by Dr. Daniel Tietjen and Dr. Martin Jäger

Click here to find out more
White microscope on yellow background
Life sciences & healthcare

Regional Court of Bochum decides on the advertising of a free hearing test with a raffle

12 May 2023
Quick read

by Dr. Daniel Tietjen and Ennio Schwind, LL.M. Eur.

Click here to find out more
Close-Up Of Lady Justice
Patents & innovation

Where are the new regulations on cannabis going? Decriminalisation in designated cannabis clubs and hesitant liberalisation by the state

17 April 2023
Quick read

by Dr. Daniel Tietjen and Dr. Martin Jäger

Click here to find out more
Futuristic man
Life sciences & healthcare

AI software ChatGPT – actually a medical device?

27 March 2023
Briefing

by Dr. Daniel Tietjen and Ennio Schwind, LL.M. Eur.

Click here to find out more

Related people

Meet me at

There are no upcoming events